Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6774)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 18, 2017 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yamagiwa S, Ishikawa T, Waguri N, Sugitani S, Wakabayashi H, Ohkoshi S, Tsukishiro T, Takahashi T, Watanabe T, Terai S. Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C. World J Hepatol 2017; 9(5): 252-262 [PMID: 28261382 DOI: 10.4254/wjh.v9.i5.252] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i5/252.htm |
| Number | Citing Articles |
| 1 |
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan. Journal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
|
| 2 |
Chung-Feng Huang, Ming-Lung Yu. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments. Expert Opinion on Pharmacotherapy 2017; 18(17): 1867 doi: 10.1080/14656566.2017.1400010
|